Explore our licensing opportunities
We create the technologies and therapies of tomorrow through open dialogue with our many partners.
FLIP: Rapid Production of Conditional KO Cells and Model Animals
“FLIP” is a method developed by scientists at the Sanger Institute and Cambridge University that considerably improves speed, affordability, scale and ...
HipSci Lines: Highly Characterised Human Induced Pluripotent Stem Cells
150+ cell lines derived from phenotypically healthy donors as part of the Human Pluripotent Stem Cell Initiative (HipSci) www.hipsci.org
INSIGHT: A Scalable Isothermal NASBA-Based Platform for COVID-19 Diagnosis
INSIGHT is a COVID testing strategy designed by the Sanger Institute scientists that could be developed as a point of care ...
ISOTYPER: Antibody Immunosequencing with Parallel Isotyping
High-throughput sequencing of immune receptors (TCRs or antibodies) has developed into a technology field in its own right: immunosequencing. It allows ...
MCMS: Mouse Colony Management System
A bespoke UX optimised system built on more than a decade of close collaboration with researchers, scientists, and technicians encapsulating all ...
NANOSEQ: Nanorate sequencing, ultra-accurate detection of somatic mutations
Nanorate sequencing (Nanoseq), is a method developed by scientists at the Sanger Institute that reduces error rates to less than 5 ...